How Do Genome-Reduced Chassis Strains Improve Plasmid Stability and Protein Yield: A Mechanism Guide

Genome-reduced chassis strains are bacterial hosts from which selected non-essential genomic regions, such as insertion sequences and other mobile elements, have been removed.

Scope note: the mechanisms described here apply to live bacterial host cells. Plasmid copy number, segregation and selection pressure are properties of the growing host population, not of lysates or cell-free reactions, and results obtained in one species or strain should not be assumed to transfer to another without testing.

Overview: plasmids, chassis, and two linked problems

Plasmids are semi-autonomous genetic elements that replicate in step with the host cell chromosome. Equivalent elements are found in organisms from all three kingdoms, although most molecular-genetic research on plasmid systems has used plasmids isolated from eubacterial hosts. A plasmid is not a passive passenger: it carries its own replication functions, its own stable-maintenance functions, and often the machinery for conjugative spread. Those functions are collectively described as the plasmid “survival kit,” and their expression is usually tightly regulated rather than constitutive, because unchecked expression would impose an unacceptable metabolic burden on the host cell.

That point about burden is the hinge between plasmid biology and chassis engineering. A production plasmid added to a bacterial cell asks the host for nucleotides, amino acids, energy, and biosynthetic capacity. A genome-reduced chassis is built on the premise that some of the host’s native capacity is dispensable, or at least less valuable than the heterologous function being produced. When non-essential genomic content is removed, the resources that would have gone into native biosynthesis can, in principle, be redirected toward the plasmid-encoded product and toward the machinery needed to secrete it.

Two outcomes are often discussed together: improved plasmid stability and improved protein yield. They are related but not identical. Protein yield is a flux and capacity problem—how much carbon and nitrogen reach the product, and how efficiently the secretory apparatus can handle it. Plasmid stability is a replication and inheritance problem—whether the plasmid is retained and correctly partitioned as cells grow and divide. A chassis change can affect both, but through different mechanisms, and the evidence for one does not automatically establish the other.

Relieving metabolic burden by removing competing biosynthetic capacity

The clearest documented route is removal of native biosynthetic clusters that consume carbon and reduce the host’s available capacity. In Streptomyces lividans TK24, a large genome contains twenty-nine non-essential clusters that direct biosynthesis of secondary metabolites. Ten chassis strains were constructed by deleting different combinations of specialized metabolite clusters—including the blue actinorhodin (act), calcium-dependent antibiotic (cda), undecylprodigiosin (red), coelimycin A (cpk), and melanin (mel) clusters—together with hrdD, which encodes a non-essential sigma factor, and matAB, a locus that affects mycelial aggregation.

The design logic was explicit: genome reduction was intended to reduce carbon flow toward specialized metabolite biosynthesis so that secreted heterologous protein production could be optimized. The inclusion of a sigma factor gene and a morphology-affecting locus alongside the secondary-metabolite clusters shows that the chassis concept was not limited to deleting pigment pathways. Regulatory capacity and growth morphology were treated as part of the production problem, because both influence how the culture behaves and how resources are allocated.

Two of the resulting S. lividans chassis strains showed roughly a 15% reduction in biomass yield, a two-fold increase in the mass yield of their total native secretome, and enhanced abundance of several secreted proteins relative to the parental strain. That combination is important: the strains did not simply grow better or make more cells. They made less biomass but secreted substantially more protein mass, which is the trade-off a secreted-protein production process is often willing to accept.

Comparable streamlining has been performed in Pseudomonas putida KT2440, where large-scale deletion of genomic islands was combined with promoter engineering to construct minimal-genome cell factories for medium-chain-length polyhydroxyalkanoate production. A 13-genomic-island and upp-deleted derivative, KTU-U13, served as the starting strain for further deletions. The resulting minimal-genome strains KTU-U24 and KTU-U27 carried reductions of 7.19% and 8.35% relative to the KT2440 genome size and were reported to be advantageous over both the upp deletion strain and KTU-U13 in several physiological traits, including maximum specific growth rate and plasmid transformation efficiency.

That last detail connects genome reduction directly to plasmid handling. Transformation efficiency is not the same as plasmid stability during long-term culture, but it is an early indicator that a host’s barriers to incoming DNA—and its general physiological condition—have shifted in a favorable direction.

Reshaping the secretory pathway rather than simply emptying the cell

A naive model of genome reduction predicts that deleting native secreted proteins simply frees secretory capacity for the heterologous product. The S. lividans data suggest something more complicated. RNA-sequencing and proteomic analysis of the secretome indicated that genome reduction led to cell wall and oxidative stresses and was accompanied by up-regulation of secretory chaperones and of secDF, a component of the Sec pathway. In other words, the chassis was not a quiet, emptied background. It was a cell responding to envelope stress and adjusting its protein-handling machinery.

This matters for interpreting yield gains. Higher secretion of a heterologous protein can arise from several non-exclusive causes: more secretory machinery available, more efficient transit through the Sec pathway, altered folding and quality control, changed membrane or cell wall properties, or a shift in the balance between native and heterologous cargo. The observed up-regulation of chaperones and secDF is consistent with the secretory pathway being remodeled rather than merely relieved of competition. It also warns that the benefit may be conditional on the protein being secreted and on how that protein interacts with the host’s folding and envelope systems.

The heterologous output data reinforce the point that effects are protein-specific. In one of the S. lividans chassis strains, secretion of the heterologous proteins mRFP and mTNFα was 12% and 70% higher, respectively, than secretion by the parental strain. A 12% gain and a 70% gain in the same host background indicate that the chassis effect is not a single uniform multiplier. The two proteins differ in sequence, folding behavior, and likely in their interaction with the secretory pathway, so the same chassis change can help one much more than the other.

Why a leaner host can be a more stable host for a plasmid

Plasmid stability is usually described in terms of the survival kit: replication, stable maintenance in the host population, and spread from bacterium to bacterium by conjugative transfer. A plasmid that replicates in step with the chromosome but partitions poorly, or that is lost at a high rate relative to its transmission, will decline in a population unless it provides a phenotypic advantage. Genome reduction can influence several terms in that balance at once.

The first route is burden relief. If native biosynthetic clusters are consuming carbon and precursor flux, the plasmid-bearing cell has less headroom before the combined cost of host functions and plasmid functions becomes growth-limiting. Because plasmid survival functions are themselves regulated to avoid unacceptable burden, the host’s baseline metabolic load sets the context in which that regulation operates. A leaner host can therefore make plasmid carriage less penalizing, which indirectly favors retention of plasmid-bearing cells in a competitive population.

The second route is the coupling of replication to segregation. The tripartite Escherichia coli work illustrates the principle clearly. In that study, the roughly 3-Mb chromosome of a genome-reduced strain was split into three approximately 1-Mb chromosomes. The first retained the original replication origin (oriC) and partitioning (par) system; the second carried an oriC and a par locus from the F plasmid; and the third carried the origin and par locus of the Vibrio tubiashii secondary chromosome. Each synthetic replicon was paired with an inheritance system, which is exactly the architecture that plasmid stability depends on.

The same study also showed the limits of that architecture. The first split chromosome could not coexist with another chromosome carrying the same origin region, while the second and third chromosomes could be individually electroporated into competent cells. The first chromosome could, however, be exchanged via conjugation between tripartite-genome strains using different selection markers. Replication origins define compatibility, and partitioning systems define whether a replicon is reliably inherited—principles that apply to production plasmids as much as to synthetic chromosomes.

The third route is physiological condition. In P. putida, the minimal-genome strains were reported to have improved maximum specific growth rate and plasmid transformation efficiency. Faster growth does not by itself prove better plasmid retention, but it changes the competitive landscape: if plasmid-bearing cells grow closer to the rate of plasmid-free cells, the selection pressure needed to maintain the plasmid is lower. Conversely, a chassis that grows more slowly or carries envelope stress may lose any advantage.

This is where honesty about the evidence matters. The available chassis studies document secretome mass yield, specific heterologous protein output, growth rate, and transformation efficiency. They do not provide strain-specific plasmid retention curves. The stability argument is therefore mechanistic and inferential: genome reduction lowers competing metabolic demand, removes some sources of native biosynthetic flux, and can improve the host’s physiological state, all of which are expected to reduce the fitness cost of plasmid carriage. Direct measurement of plasmid loss rates under production conditions remains the decisive test.

Genome-reduced strains as engineering platforms

The E. coli tripartite-genome work shows a further consequence of genome reduction: it makes large-scale restructuring possible. The tripartite cells maintained their rod-shaped form and grew only twice as slowly as their parent, which allowed further genetic engineering. A proportion of the 1-Mb chromosomes could be purified as covalently closed supercoiled molecules using a conventional alkaline lysis method and anion exchange columns, and the second and third chromosomes could be individually electroporated into competent cells.

That combination—stable inheritance, purifiable supercoiled DNA, and electroporation competence—is the practical definition of a useful replicon platform. It also highlights a cost: the tripartite strain grew about twice as slowly as its parent. Genome reduction and genome restructuring can buy controllability and manipulability at the price of growth rate, and the balance has to be settled experimentally for each process.

Practical considerations and trade-offs

The first practical point is that genome reduction is not a free gain.

Frequently Asked Questions